Everything You Should Know About Bilibili (BILI) Rating Increase to Buy
Bilibili's Upgrade: Bilibili (BILI) has been upgraded to a Zacks Rank #2 (Buy) due to a significant increase in earnings estimates, indicating a positive outlook for the company's stock price.
Zacks Rating System: The Zacks rating system, which focuses on earnings estimate revisions, has a strong track record of predicting stock movements, with Zacks Rank #1 stocks averaging a +25% annual return since 1988.
Earnings Estimates: Analysts have raised Bilibili's earnings estimates by 33.3% over the past three months, reflecting an improvement in the company's underlying business and potential for stock price appreciation.
Market Position: Bilibili's placement in the top 20% of Zacks-covered stocks suggests it has superior earnings estimate revisions, making it a strong candidate for market-beating returns in the near term.
Trade with 70% Backtested Accuracy
Analyst Views on BILI
About BILI
About the author

Gelteq Ltd Reports 22% Bioavailability Increase in Cannabinoid Oral Gel, Shares Surge 50.1%
- Bioavailability Improvement: Gelteq Ltd's oral gel delivery platform achieved over a 22% increase in bioavailability compared to an FDA-approved oil-based product in preclinical trials, indicating significant technological advantages that could enhance market acceptance and drive future sales growth.
- Stock Surge: Following this positive announcement, Gelteq's shares surged 50.1% in pre-market trading to $1.25, reflecting strong investor confidence in the new technology and its market potential.
- Enhanced Market Competitiveness: By improving product bioavailability, Gelteq not only meets the growing consumer demand but also positions itself more favorably in the competitive pharmaceutical market, potentially driving the company's long-term strategic development.
- Increased Investor Interest: With Gelteq's technological advancements and stock price increase, market attention on its future performance has significantly risen, likely attracting more investors and partners, thereby facilitating the company's capital operations and business expansion.

Bitget Lists 98 New US Stocks and ETFs, Expanding Trading Platform
- Market Access Expansion: Bitget's collaboration with Ondo introduces 98 new US stocks and ETFs, significantly enhancing user access to traditional markets and advancing its multi-asset trading environment.
- Asset Diversification: The new assets include short-duration Treasury strategies and international growth stocks like BILI and PDD, which enhance user participation in global market cycles and strengthen the platform's competitive edge.
- Increased Trading Flexibility: Users can trade over 200 stock tokens via USDT settlement, simplifying the need for traditional brokerage accounts and enhancing the trading experience for digital-native participants.
- Strategic Vision Advancement: This expansion further propels Bitget's UEX vision, aiming to unify digital assets with traditional financial instruments, thereby enhancing platform liquidity and usability to meet the needs of a new generation of financial investors.






